Boston Scientific, a world leader in medical device manufacturing with a mission to transform lives through innovative medical solutions ...
In addition, technological advancements such as the increasing use of AI, predictive analysis, and advanced algorithms are ...
Tipperary's county councillors voted overwhelmingly in favour of accepting the Tipperary N&B Association's invitation to send ...
Stifel analysts increased their price target on Boston Scientific Corporation (NYSE:BSX) shares from $115.00 to $120.00, while reiterating a Buy rating for the medical device company. The adjustment ...
A “life-changing” device being developed in Clonmel needs to be made available to patients in Ireland. That was the fundamental take-home from Boston Scientific Clonmel’s annual Everybody Makes an ...
The table above is the complete Clonmel Ramadan Calendar 2025. Here you can see the Sehri timing and iftar timing in Clonmel from the first to the last Ramadan fasting day. The Islamic and Gregorian ...
The team trained a machine-learning algorithm to analyse the text of the papers and classify the research according to scientific categories laid out by the NIH, such as ‘chronic pain’ or ...
The U.S. Food and Drug Administration (FDA) has issued a safety communication noting the potential need for early device replacement of Boston Scientific Corporation Accolade pacemaker devices.
Credit: Shutterstock / Good dreams – Studio US healthtech giant Boston Scientific’s pulmonary vein isolation (PVI) device trial has met its primary endpoint in patients with paroxysmal atrial ...
In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price target of $110.00. The company’s shares closed ...
Boston Scientific CEO Mike Mahoney told investors the company’s PFA launch is rapidly increasing its share of the electrophysiology market, while Intuitive Surgical CEO Gary Guthart shared surgeon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results